Vincerx Pharma, Inc. - FORM S-1/A - EX-99.5 - EXHIBIT 99.5 - February 27, 2020

Attached files

file filename
EX-99.4 - EXHIBIT 99.4 - Vincerx Pharma, Inc.tm2010974d1_ex99-4.htm
EX-99.8 - EXHIBIT 99.8 - Vincerx Pharma, Inc.tm2010974d1_ex99-8.htm
EX-99.7 - EXHIBIT 99.7 - Vincerx Pharma, Inc.tm2010974d1_ex99-7.htm
EX-99.6 - EXHIBIT 99.6 - Vincerx Pharma, Inc.tm2010974d1_ex99-6.htm
EX-99.3 - EXHIBIT 99.3 - Vincerx Pharma, Inc.tm2010974d1_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - Vincerx Pharma, Inc.tm2010974d1_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Vincerx Pharma, Inc.tm2010974d1_ex99-1.htm
EX-23.1 - EXHIBIT 23.1 - Vincerx Pharma, Inc.tm2010974d1_ex23-1.htm
EX-14 - EXHIBIT 14 - Vincerx Pharma, Inc.tm2010974d1_ex14.htm
EX-10.6 - EXHIBIT 10.6 - Vincerx Pharma, Inc.tm2010974d1_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - Vincerx Pharma, Inc.tm2010974d1_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - Vincerx Pharma, Inc.tm2010974d1_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Vincerx Pharma, Inc.tm2010974d1_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Vincerx Pharma, Inc.tm2010974d1_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Vincerx Pharma, Inc.tm2010974d1_ex10-1.htm
EX-5.1 - EXHIBIT 5.1 - Vincerx Pharma, Inc.tm2010974d1_ex5-1.htm
EX-4.4 - EXHIBIT 4.4 - Vincerx Pharma, Inc.tm2010974d1_ex4-4.htm
EX-4.3 - EXHIBIT 4.3 - Vincerx Pharma, Inc.tm2010974d1_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - Vincerx Pharma, Inc.tm2010974d1_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - Vincerx Pharma, Inc.tm2010974d1_ex4-1.htm
EX-3.3 - EXHIBIT 3.3 - Vincerx Pharma, Inc.tm2010974d1_ex3-3.htm
EX-3.2 - EXHIBIT 3.2 - Vincerx Pharma, Inc.tm2010974d1_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Vincerx Pharma, Inc.tm2010974d1_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Vincerx Pharma, Inc.tm2010974d1_ex1-1.htm
S-1/A - S-1/A - Vincerx Pharma, Inc.tm2010974d1_s1a.htm

 

Exhibit 99.5

 

CONSENT

 

LifeSci Acquisition Corp. intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto the “Registration Statement”), registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.

 

/s/ Barry Dennis

Barry Dennis  

 

Date: February 27, 2020

 

 

 

Vincerx Pharma, Inc. Reports